Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," ...

The average age of men who get diagnosed is 67.

Many patients with metastatic cancers receive therapy that is initially highly effective, often resulting in complete remission. However, cancer cells have a remarkable capacity to evolve resistance ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

Medically reviewed by Kathleen Daly, MD One out of every eight men in the U.S. will experience prostate cancer, and that rate ...

A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help ...

In a new study published in the journal Nature Genetics, Haolong Li, PhD, a researcher at Fred Hutch Cancer Center, and colleagues developed a way to monitor androgen receptor levels inside living ...

Incontinence and other urinary problems after prostate cancer treatment can be eased with Kegel exercises, bladder training, ...

By KATRINA BRANDON DONATIONS have opened up opportunities at Latrobe Regional Hospital (LRH) thanks to Latrobe's Biggest Ever ...

Living with prostate cancer can be very stressful. It can affect a person’s body, life plans, relationships, and emotions. Many people don’t realize that people with prostate cancer are at risk for ...